A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

RECRUITING

NCT05283993

Sponsor: Peking University First Hospital

Summary

The primary aim is to establish a prospective cohort of patients with plasma cell disorders (PCDs). All of the hospitalized PCD patients who are willing to sign the informed consent form (ICF) will be included in this study. Clinical characteristics, treatment options and responses will be collected. Peripheral blood, bone marrow aspirate and urine samples before and after the treatment will banked for future research. Our team will focus on the clinical and pathological features of PCDs, the correlation between the minimal residual disease (MRD) status and prognosis, and the role of Tumor Microenvironment (TME) in the pathogenesis and progress of PCDs.

Official title: A Prospective Cohort Study of Patients With Plasma Cell Disorders (PCDs) in PKUFH

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

2000

Start Date

2021-07-01

Completion Date

2030-12-31

Last Updated

2022-04-25

Healthy Volunteers

Yes

Conditions

Multiple Myeloma Amyloidosis Cryoglobulinemia Castleman's Disease Light Chain Deposition Disease Heavy Chain Deposition Disease Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes Smoldering Multiple Myeloma Plasma Cell Leukemia Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Renal Significance (MGRS)Monoclonal Gammopathy of Neurological Significance (MGNS)

Interventions

OTHER

No intervention

Locations (1)

Peking University First Hospital

Beijing, China

Clinical Research Directory